Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Tech · Finance Services

CoreWeave, Inc. to acquire Core Scientific, Inc.

Announced Jul 7, 2025 · Terminated Oct 30, 2025

Deal value$9.00B
Premium66.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock$20.40 per share

Transaction

Acquirer
CoreWeave, Inc. (CRWV)
Target
Core Scientific, Inc. (CORZ)
Buyer type
Strategic
Offer price per share
$20.40
Enterprise value
—
Status
Terminated Oct 30, 2025

Deal protections

Break fee (target pays)
$270M · 3.0%
Reverse fee (buyer pays)
—
Go-shop
—
Financing
—

Advisors

To the acquirer
Goldman Sachs
To the target
Moelis, PJT Partners
Moelis fee
$2.0M
PJT Partners fee
$10.0M

Sector context · Tech

Comparable deals
62 in the prior 24 months
Premium
66.0% vs. 37.0% sector median
EV / Adj. EBITDA
Sector median 16.7x
Break fee
3.0% vs. 3.0% sector median

Timeline

  1. AnnouncedJul 7, 2025
  2. Proxy filedSep 26, 2025
  3. Definitive proxySep 26, 2025
  4. Shareholder voteOct 30, 2025
  5. TerminatedOct 30, 2025

Valuation · fairness opinions

Discounted cash flowMoelis$12.09$22.94
Trading comparablesMoelis$14.66$20.74
Trading comparablesMoelis$18.85$27.73
Discounted cash flowPJT Partners$13.17$18.47
52-week trading rangePJT Partners$6.20$18.63
Analyst price targetsPJT Partners$15.00$20.00
Offer $20.40

Implied value per Core Scientific, Inc. share by analysis, from Moelis and PJT Partners.

Sources
  • 8-K (EX-99.1) · Jul 7, 2025
  • 8-K (EX-99.1) · Jul 7, 2025
  • 425 (EX-99.1) · Jul 7, 2025
  • 425 · Jul 7, 2025
  • 8-K · Jul 7, 2025
  • 425 · Oct 22, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.